![GeneXpert®: un outil particulièrement adapté à la prise en charge hospitalière des cas de COVID-19 et à la gestion et au suivi de cette épidémie dans les pays du Sud. - Institut GeneXpert®: un outil particulièrement adapté à la prise en charge hospitalière des cas de COVID-19 et à la gestion et au suivi de cette épidémie dans les pays du Sud. - Institut](https://i0.wp.com/www.pasteur.mg/wp-content/uploads/2020/10/Gxpt-2.jpg?resize=696%2C465&ssl=1)
GeneXpert®: un outil particulièrement adapté à la prise en charge hospitalière des cas de COVID-19 et à la gestion et au suivi de cette épidémie dans les pays du Sud. - Institut
![A Rapid Test for Covid-19 Arrives Via a 20-year-old Technology Already in Many Hospitals - IEEE Spectrum A Rapid Test for Covid-19 Arrives Via a 20-year-old Technology Already in Many Hospitals - IEEE Spectrum](https://assets.rbl.ms/25591293/origin.jpg)
A Rapid Test for Covid-19 Arrives Via a 20-year-old Technology Already in Many Hospitals - IEEE Spectrum
![Civil society response to Cepheid, donors and countries calling for access to GeneXpert COVID-19 tests | Médecins Sans Frontières Access Campaign Civil society response to Cepheid, donors and countries calling for access to GeneXpert COVID-19 tests | Médecins Sans Frontières Access Campaign](https://msfaccess.org/sites/default/files/styles/msf_wide/public/2022-10/TB_Armenia_Genexpert_AndreaBussotti_2014_MSB7113_2048px.JPG.webp?itok=gEoZxJDM)
Civil society response to Cepheid, donors and countries calling for access to GeneXpert COVID-19 tests | Médecins Sans Frontières Access Campaign
![Cepheid Receives World Health Organization Pre-Qualification of Xpert HIV-1 Viral Load Test (Updated) - African Society for Laboratory Medicine Cepheid Receives World Health Organization Pre-Qualification of Xpert HIV-1 Viral Load Test (Updated) - African Society for Laboratory Medicine](https://www.aslm.org/wp-content/uploads/2017/08/xpert-HIV-1-aug-28-2017.png?x89467)
Cepheid Receives World Health Organization Pre-Qualification of Xpert HIV-1 Viral Load Test (Updated) - African Society for Laboratory Medicine
![PLOS ONE: Public investments in the development of GeneXpert molecular diagnostic technology | Médecins Sans Frontières Access Campaign PLOS ONE: Public investments in the development of GeneXpert molecular diagnostic technology | Médecins Sans Frontières Access Campaign](https://msfaccess.org/sites/default/files/styles/teaser_multi_column_background_480x410/public/2021-02/HEP-C_India_GenexpeertTesting_2017_RaviMishra_MSF221020_3800px.jpg.webp?itok=CtvlZrM-)